NCT02723240View on ClinicalTrials.gov

NUC-3373 in Advanced Solid Tumours

PHASE1CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

February 24, 2020

Study Completion Date

February 24, 2021

Conditions
Cancer
Interventions
DRUG

NUC-3373

Trial Locations (3)

BT9 7AB

Belfast City Hospital, Belfast

G12 OYN

Beatson, West of Scotland Cancer Centre, Glasgow

OX3 7LE

Oxford University Hospitals NHS Trust, Oxford

All Listed Sponsors
lead

University of Oxford

OTHER

NCT02723240 - NUC-3373 in Advanced Solid Tumours | Biotech Hunter | Biotech Hunter